Know what diseases fall under Rare Diseases category indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.
Text Size:
A+
New Delhi: Two figures and a looming deadline have raised a question around India’s Covid vaccination drive.
India has administered roughly as many Covid vaccine doses within the country as it has sent for commercial exports. However, even as the earliest batches of the Covid vaccines are set to expire next month, the government refuses to allow domestic commercial sales.
Covishield and Covaxin, the two vaccines being used in India, were granted emergency use authorisation on 3 January. Since 16 January, when the Covid vaccination drive was rolled out in India, 3.48 crore doses have been administered in the country. Meanwhile, India has commercially exported 3.39 crore doses to countries around the world since the first of these batches went out to Morocco and Brazil on 22 January.
EXCLUSIVE-Pfizer withdraws application for emergency use of its COVID-19 vaccine in India reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Madras HC issues notice to Centre on plea to declare Covishield vaccine as unsafe
February 19, 2021
Litigant, who volunteered for trials, claims he suffered side-effects, seeks ₹5-crore compensation
The Madras High Court on Friday issued notice to the Centre on a writ petition filed by a litigant to declare Covishield vaccine of Serum Institute of India as unsafe. The litigant, a business consultant who had volunteered for the trials, claimed that he had suffered from side-effects and that he must be compensated with ₹5 crore, or any other amount as decided by the Court.
In November 2020, the litigant sent a legal notice to Serum Institute of India asking for the compensation and asked the Centre and ICMR not to give any approval to manufacture and distribute the vaccine.
Read more about Madras HC notice to Centre on plea to declare Covishield vaccine as unsafe on Business Standard. The petitioner, 41-year old Asif Riaz, also sought an interim injunction restraining the Central government and the Drugs Controller General of India from continuing with administering Covishield